New targets and strategies in treatment of metastatic gastric cancer.
1/5 보강
[INTRODUCTION] Gastric cancer is a common type of cancer and one of the leading causes of cancer-related deaths.
APA
Simsek M, Turk HM (2025). New targets and strategies in treatment of metastatic gastric cancer.. Future oncology (London, England), 21(22), 2931-2940. https://doi.org/10.1080/14796694.2025.2547562
MLA
Simsek M, et al.. "New targets and strategies in treatment of metastatic gastric cancer.." Future oncology (London, England), vol. 21, no. 22, 2025, pp. 2931-2940.
PMID
40819954 ↗
Abstract 한글 요약
[INTRODUCTION] Gastric cancer is a common type of cancer and one of the leading causes of cancer-related deaths. Unfortunately, the number of cases has been rising in recent years. Since this cancer often does not show symptoms in its early stages, most people are diagnosed when the disease is already advanced (stage 3 or 4). At this stage, survival rates are low, with most patients living about 12 months on average.
[TREATMENT OPTIONS] For advanced gastric cancer, the most commonly used treatments are chemotherapy combinations that include oxaliplatin and fluoropyrimidine. Another option is irinotecan, which can be used instead of oxaliplatin. However, older drugs like anthracyclines and docetaxel are no longer widely used. A newer combination of oxaliplatin, fluoropyrimidine, leucovorin, and docetaxel has fewer side effects compared to older treatments.
[RECENT ADVANCES] In recent years, researchers have discovered new ways to target gastric cancer. These include therapies that combine antibodies with drugs, therapies that use multiple antibodies, and immunotherapies that help the immune system fight cancer. These new treatments, when added to chemotherapy, offer hope for improving survival rates in people with advanced gastric cancer.
[TREATMENT OPTIONS] For advanced gastric cancer, the most commonly used treatments are chemotherapy combinations that include oxaliplatin and fluoropyrimidine. Another option is irinotecan, which can be used instead of oxaliplatin. However, older drugs like anthracyclines and docetaxel are no longer widely used. A newer combination of oxaliplatin, fluoropyrimidine, leucovorin, and docetaxel has fewer side effects compared to older treatments.
[RECENT ADVANCES] In recent years, researchers have discovered new ways to target gastric cancer. These include therapies that combine antibodies with drugs, therapies that use multiple antibodies, and immunotherapies that help the immune system fight cancer. These new treatments, when added to chemotherapy, offer hope for improving survival rates in people with advanced gastric cancer.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Clinical Presentation and Outcomes of Patients Undergoing Surgery for Thyroid Cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.